Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal

Journal of Medicinal Chemistry
Leonardo Di NunnoPaola Patrignani

Abstract

3,4-Diarylisoxazole analogues of valdecoxib [4-(5-methyl-3-phenylisoxazol-4-yl)-benzensulfonamide], a selective cyclooxygenase-2 (COX-2) inhibitor, were synthesized by 1,3-dipolar cycloaddition of arylnitrile oxides to the enolate ion of phenylacetone regioselectively prepared in situ with lithium diisopropylamide at 0 degrees C. The corresponding 3-aryl-5-methyl-4-phenylisoxazoles were easily generated by a dehydration/aromatization reaction under basic conditions of 3-aryl-5-hydroxy-5-methyl-4-phenyl-2-isoxazolines and further transformed into their benzenesulfonamide derivatives. The biochemical COX-1/COX-2 selectivity was evaluated in vitro by using the human whole blood assays of COX isozyme activity. Three compounds not bearing the sulfonamide group present in valdecoxib were selective COX-1 inhibitors.

References

Apr 1, 1979·Journal of Endocrinological Investigation·G CiabattoniC Patrono
Jun 1, 1982·The Journal of Clinical Investigation·P PatrignaniC Patrono
Dec 1, 1994·The Journal of Clinical Investigation·R C HarrisM D Breyer
May 20, 1999·The Journal of Clinical Investigation·B RoccaG A FitzGerald
Jun 23, 1999·Proceedings of the National Academy of Sciences of the United States of America·P J JakobssonB Samuelsson
Aug 7, 1999·The Journal of Biological Chemistry·L J MarnettC A Lanzo
Jan 22, 2000·Journal of the Society for Gynecologic Investigation·D A Kniss
Feb 15, 2000·American Journal of Respiratory and Critical Care Medicine·E A Dennis
Nov 23, 2000·The New England Journal of Medicine·C BombardierUNKNOWN VIGOR Study Group
Jun 8, 2001·The Journal of Clinical Investigation·F A Fitzpatrick, R Soberman
Aug 11, 2001·The New England Journal of Medicine·G A FitzGerald, C Patrono
Sep 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·N V ChandrasekharanDaniel L Simmons
Sep 25, 2002·Drugs·Douglas OrmrodAntona J Wagstaff
Oct 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Timothy D Warner, Jane A Mitchell
Jan 16, 2003·Molecular Pharmacology·C M DooleyC T Sharkey
Feb 5, 2003·Current Medical Research and Opinion·Stefania TacconelliPaola Patrignani
Mar 28, 2003·Lancet·Jan M SchwabStefan Laufer
Dec 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jan M SchwabHermann J Schluesener
Mar 3, 2004·International Journal of Cancer. Journal International Du Cancer·Tomohiro KitamuraKeiji Wakabayashi

❮ Previous
Next ❯

Citations

May 17, 2014·European Journal of Medicinal Chemistry·Maria Grazia PerroneAntonio Scilimati
Jul 1, 2009·Expert Opinion on Therapeutic Patents·Teodorico C RamalhoMatheus P Freitas
Oct 18, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Rosa CalvelloAntonio Scilimati
Aug 21, 2010·European Journal of Medicinal Chemistry·Sureshbabu Dadiboyena, Adel Nefzi
Feb 26, 2008·Thrombosis Research·Silvia RiondinoFabio M Pulcinelli
Jan 27, 2012·ChemMedChem·Maria Grazia PerroneAntonio Scilimati
Oct 17, 2014·Medicinal Research Reviews·Sharad Kumar Suthar, Manu Sharma
Feb 18, 2014·European Journal of Medicinal Chemistry·Paola VitaleAntonio Scilimati
Apr 26, 2016·Medicinal Research Reviews·Paola VitaleMaria Grazia Perrone
May 3, 2016·ChemMedChem·Maria Grazia PerroneAntonio Scilimati
Oct 3, 2018·SAR and QSAR in Environmental Research·Y XiA Yan
Feb 23, 2018·Chemical Communications : Chem Comm·Navaneet KumarAtul Kumar
Feb 24, 2021·Scientific Reports·Morena MiciacciaAntonio Scilimati
Aug 10, 2016·Bioorganic & Medicinal Chemistry·Bernice LinK N Houk
Jun 1, 2021·ACS Medicinal Chemistry Letters·Jatinder KaurFrank Wuest
Nov 20, 2014·ACS Medicinal Chemistry Letters·Md Jashim UddinLawrence J Marnett
Feb 15, 2019·Journal of Chemical Information and Modeling·Zijian QinAixia Yan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.